BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15467426)

  • 21. SEREX analysis of gastric cancer antigens.
    Obata Y; Takahashi T; Sakamoto J; Tamaki H; Tominaga S; Hamajima N; Chen YT; Old LJ
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S37-42. PubMed ID: 10950146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigens recognized by autologous antibody in patients with renal-cell carcinoma.
    Scanlan MJ; Gordan JD; Williamson B; Stockert E; Bander NH; Jongeneel V; Gure AO; Jäger D; Jäger E; Knuth A; Chen YT; Old LJ
    Int J Cancer; 1999 Nov; 83(4):456-64. PubMed ID: 10508479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
    Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
    Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of tumor-associated autoantigens with SEREX.
    Türeci O; Usener D; Schneider S; Sahin U
    Methods Mol Med; 2005; 109():137-54. PubMed ID: 15585919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
    Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old LJ; Nakayama E
    Int J Cancer; 2000 Dec; 88(6):845-51. PubMed ID: 11093803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of Targets for Cancer Immunoprevention.
    Cappello P; Bulfamante S; Mandili G; Novelli F
    Methods Mol Biol; 2022; 2435():19-33. PubMed ID: 34993937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigens.
    Zwick C; Preuss KD; Kubuschok B; Held G; Ahlgrimm M; Bittenbring J; Schubert J; Neumann F; Pfreundschuh M
    Ann Hematol; 2009 Oct; 88(10):999-1003. PubMed ID: 19238384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity.
    Krause P; Türeci O; Micke P; Buhl R; Huber C; Sahin U
    J Immunol Methods; 2003 Dec; 283(1-2):261-7. PubMed ID: 14659917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
    Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
    Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
    Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
    Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The construction of cDNA library and the screening of related antigen of ascitic tumor cells of ovarian cancer.
    Hou Q; Chen K; Shan Z
    Eur J Gynaecol Oncol; 2015; 36(5):590-4. PubMed ID: 26513889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological analysis of human tumor antigens: molecular definition and implications.
    Türeci O; Sahin U; Pfreundschuh M
    Mol Med Today; 1997 Aug; 3(8):342-9. PubMed ID: 9269687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.
    Behrends U; Schneider I; Rössler S; Frauenknecht H; Golbeck A; Lechner B; Eigenstetter G; Zobywalski C; Müller-Weihrich S; Graubner U; Schmid I; Sackerer D; Späth M; Goetz C; Prantl F; Asmuss HP; Bise K; Mautner J
    Int J Cancer; 2003 Aug; 106(2):244-51. PubMed ID: 12800201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomic analysis of human sarcoma.
    Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serological screening of xenogeneic antigens from rat testis].
    Peng F; Tian L; Deng HX; Li Y; Yang HS; Kan B; Zhao X; Liao J; Wei YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):305-8. PubMed ID: 15181820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of prostate cancer antigens by automated high-throughput filter immunoscreening.
    Alsøe L; Stacy JE; Fosså A; Funderud S; Brekke OH; Gaudernack G
    J Immunol Methods; 2008 Jan; 330(1-2):12-23. PubMed ID: 18045611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.
    Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M
    Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells.
    Ehlken H; Schadendorf D; Eichmüller S
    Int J Cancer; 2004 Jan; 108(2):307-13. PubMed ID: 14639620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of lymphoma-associated antigens using SEREX.
    Liggins AP; Guinn BA; Banham AH
    Methods Mol Med; 2005; 115():109-28. PubMed ID: 15998965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer immunotherapy in clinical oncology.
    Knuth A; Jäger D; Jäger E
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S46-51. PubMed ID: 10950148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.